The efficacy and safety of TNF inhibitor (golimumab) as salvage treatment in patients with refractory noninfectious uveitis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-022-01019-6.pdf
Reference27 articles.
1. Blauvelt A et al (2022) Long-term treatment patterns among patients with psoriasis treated with ixekizumab or adalimumab: a real-world study. J Drugs Dermatol 21:399–407. https://doi.org/10.36849/JDD.6336
2. Borras-Blasco J, Castera DE, Cortes X, Abad FJ, Rosique-Robles JD, Mallench LG (2015) Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults. Int J Clin Pharmacol Ther 53:377–390. https://doi.org/10.5414/CP202171
3. Cordero-Coma M et al (2014) Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience. Mediators Inflamm 2014:717598. https://doi.org/10.1155/2014/717598
4. Curtis JR et al (2021) Incidence of infusion reactions and clinical effectiveness of intravenous golimumab versus infliximab in patients with rheumatoid arthritis: the Real-World AWARE Study. Rheumatol Ther 8:1551–1563. https://doi.org/10.1007/s40744-021-00354-4
5. Dave MB et al (2020) Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammatory bowel disease: an audit. Indian J Gastroenterol 39:426–434. https://doi.org/10.1007/s12664-020-01050-x
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of golimumab in patients with refractory non-infectious panuveitis;Scientific Reports;2024-01-25
2. Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non‐infectious uveitis;Clinical & Translational Immunology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3